Innate Immunity and Non-Hodgkin's Lymphoma (NHL) Related Genes in a Nested Case-Control Study for Gastric Cancer Risk

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Park, Sue K ^a,b   Yang, Jae Jeong ^a   Oh, Sohee ^b   Cho, Lisa Y ^a   Ma, Seung Hyun ^a   Shin, Aesun ^c   Ko, Kwang Pil ^d   Park, Taesung ^b   Yoo, Keun Young ^a   Kang, Daehee ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c National Cancer Center   (South Korea)

^d Gachon University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACAA1 GENE; ADULT; AGE DISTRIBUTION; ARTICLE; BCL2L11 GENE; CAGA GENE; CANCER RISK; CASE CONTROL STUDY; CASP7 GENE; CD79B GENE; CHMP7 GENE; CHUK GENE; CLDN9 GENE; CONTROLLED STUDY; DEFA6 GENE; DEFB1 GENE; FEMALE; GENE; GENE IDENTIFICATION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HELICOBACTER INFECTION; HUMAN; INNATE IMMUNITY; INSL3 GENE; JAK3 GENE; MAJOR CLINICAL STUDY; MALE; NHL RELATED GENE; POPULATION RESEARCH; RAD50 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STOMACH CANCER; TNFRSF8 GENE; TUMOR GENE;

AGE FACTORS; AGED; ALPHA-DEFENSINS; ASIAN CONTINENTAL ANCESTRY GROUP; BETA-DEFENSINS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; INSULIN; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RISK; SMOKING; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 84866675557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045274     Document Type: Article

References (41)

1. WHO (2008) World Health Organization. Fact sheets, Cancer, In: Media Centre, World Health Organization. http://www.who.int/mediacentre/factsheets/fs297/en/index.html.
2. IARC (1994) IARC Monographs on the evaluation of carcinogenic risks to human: Schistosomes, liver flukes and Helicobacter pylori,. Lyon.
3. Lunet N, Barros H, (2003) Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer 106: 953-960.
4. Miwa H, Go MF, Sato N, (2002) H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol 97: 1106-1112.
5. Portal-Celhay C, Perez-Perez GI, (2006) Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes. Clin Sci (Lond) 110: 305-314.
6. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, et al. (2003) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124: 1193-1201.
7. Ng MT, Van't Hof R, Crockett JC, Hope ME, Berry S, et al. (2010) Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9-1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease. Infect Immun 78: 1345-1352.
8. Hellmig S, Fischbach W, Goebeler-Kolve ME, Fölsch UR, Hampe J, et al. (2005) Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma 46: 869-872.
9. Türe-Ozdemir F, Gazouli M, Tzivras M, Panagos C, Bovaretos N, et al. (2008) Association of polymorphisms of NOD2, TLR4 and CD14 genes with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Anticancer Res 28: 3697-3700.
10. Yoo KY, Shin HR, Chang SH, Lee KS, Park SK, et al. (2002) Korean Multi-center Cancer Cohort Study including a Biological Materials Bank (KMCC-I). Asian Pac J Cancer Prev 3: 85-92.
11. Gwack J, Shin A, Kim CS, Ko KP, Kim Y, et al. (2006) CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea. Br J Cancer 95: 639-641.
12. Shin A, Shin HR, Kang D, Park SK, Kim CS, et al. (2005) A nested case-control study of the association of Helicobacter pylori infection with gastric adenocarcinoma in Korea. Br J Cancer 92 92: 1273-1275.
13. Park CY, Cho YK, Kodama T, El-Zimaity HM, Osato MS, et al. (2002) New serological assay for detection of putative Helicobacter pylori virulence factors. J Clin Microbiol 40: 4753-4756.
14. Packer BR, Yeager M, Burdett L, Welch R, Beerman M, et al. (2006) SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 34: D617-621.
15. Lee JY, Park AK, Lee KM, Park SK, Han S, et al. (2009) Candidate gene approach evaluates association between innate immunity genes and breast cancer risk in Korean women. Carcinogenesis 30: 1528-1531.
16. Lin CH, Yeakley JM, McDaniel TK, Shen R, (2009) Medium- to high-throughput SNP genotyping using VeraCode microbeads. Methods Mol Biol 496: 129-142.
17. Zamar D, McNeney B, Graham J, (2007) elrm: software implementing exact-like inference for logistic regression models. J stat softw 21: 1-18.
18. Benjamini Y, Yekutieli D, (2001) The control of the false discovery rate in multiple testing under dependency. Ann Statist 29: 1165-1188.
19. Hardy RJ, Thompson SG, (1998) Detecting and describing heterogeneity in meta-analysis. Stat Med 17: 841-856.
20. Fellermann K, Stange EF, (2001) Defensins - innate immunity at the epithelial frontier. Eur J Gastroenterol Hepatol 13: 771-776.
21. Schneider JJ, Unholzer A, Schaller M, Schäfer-Korting M, Korting HC, (2005) Human defensins. J Mol Med 83: 587-595.
22. Szyk A, Wu Z, Tucker K, Yang D, Lu W, et al. (2006) Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci 15: 2749-2760.
23. Campopiano DJ, Clarke DJ, Polfer NC, Barran PE, Langley RJ, et al. (2004) Structure-activity relationships in defensin dimers: a novel link between beta-defensin tertiary structure and antimicrobial activity. J Biol Chem 279: 48671-48679.
24. Wehkamp J, Schauber J, Stange EF, (2007) Defensins and cathelicidins in gastrointestinal infections. Curr Opin Gastroenterol 23: 32-38.
25. Motzkus D, Schulz-Maronde S, Heitland A, Schulz A, Forssmann WG, et al. (2006) The novel beta-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo. FASEB J 20: 1701-1702.
26. Droin N, Hendra JB, Ducoroy P, Solary E, (2009) Human defensins as cancer biomarkers and antitumour molecules. J Proteomics 72: 918-927.
27. Uehara N, Yagihashi A, Kondoh K, Tsuji N, Fujita T, et al. (2003) Human beta-defensin-2 induction in Helicobacter pylori-infected gastric mucosal tissues: antimicrobial effect of overexpression. J Med Microbiol 52: 41-45.
28. Kon OL, Yip TT, Ho MF, Chan WH, Wong WK, et al. (2008) The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile. BMC Med Genomics 25: 54.
29. Stemmermann GN, Mesiona W, Greenwood FC, Bryant-Greenwood GD, (1994) Immunocytochemical identification of a relaxin-like protein in gastrointestinal epithelium and carcinoma: a preliminary report. J Endocrinol 140: 321-325.
30. Essner R, Huynh Y, Nguyen T, Rose M, Kojima M, et al. (2001) Functional interleukin-4 receptor and interleukin-2 receptor common gamma chain in human gastric carcinoma: a possible mechanism for cytokine-based therapy. J Gastrointest Surg 5: 81-90.
31. Micheau O, Tschopp J, (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181-190.
32. Maeda S, Yoshida H, Ogura K, Mitsuno Y, Hirata Y, et al. (2000) H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology 119: 97-108.
33. Xu H, Chaturvedi R, Cheng Y, Bussiere FI, Asim M, et al. (2004) Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res 64: 8521-8525.
34. Gross A, McDonnell JM, Korsmeyer SJ, (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911.
35. Smith L, Berrieman HK, O'Kane SL, Campbell A, Maraveyas A, et al. (2006) Immunohistochemical detection of apoptotic markers in gastric cancer. Oncol Res 15: 441-444.
36. Soung YH, Lee JW, Kim HS, Park WS, Kim SY, et al. (2003) Inactivating mutations of CASPASE-7 gene in human cancers. Oncogene 22: 8048-8052.
37. Yoo NJ, Lee JW, Kim YJ, Soung YH, Kim SY, et al. (2004) Loss of caspase-2,-6 and-7 expression in gastric cancers. APMIS 112: 330-335.
38. Cragg MS, Chan HT, Fox MD, Tutt A, Smith A, et al. (2002) The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis. Blood 100: 3068-3076.
39. Matsutani N, Yokozaki H, Tahara E, Tahara H, Kuniyasu H, et al. (2001) Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas. Pathobiology 69: 219-224.
40. Kim NG, Choi YR, Baek MJ, Kim YH, Kang H, et al. (2001) Frameshift mutations at coding mononucleotide repeats of the hRAD50 gene in gastrointestinal carcinomas with microsatellite instability. Cancer Res 61: 36-38.
41. Katoh M, (2003) CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int J Mol Med 11: 683-689.